CLINICAL OBSERVATION ON AHALYSANTINFARC-TASE TREATMENT FOR SCLERODERMA

Lai Songqing

doi:10.13406/j.cnki.cyxb.1990.04.020

您当前的位置：

首页 >

文章列表页 >

CLINICAL OBSERVATION ON AHALYSANTINFARC-TASE TREATMENT FOR SCLERODERMA

更新时间：2024-01-17

- CLINICAL OBSERVATION ON AHALYSANTINFARC-TASE TREATMENT FOR SCLERODERMA
- Journal of Chongqing Medical University Issue 4, Pages: 312-314(1990)
- 作者机构：
  
  重庆医科大学第一医院皮肤科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.1990.04.020
  CLC：
- Published：1990，
扫描看全文
[1]赖松青.蝮蛇抗栓酶治疗硬皮病的临床观察[J].重庆医科大学学报,1990(04):312-314.

Lai Songqing. CLINICAL OBSERVATION ON AHALYSANTINFARC-TASE TREATMENT FOR SCLERODERMA. [J]. Journal of Chongqing Medical University (4):312-314(1990)
[1]赖松青.蝮蛇抗栓酶治疗硬皮病的临床观察[J].重庆医科大学学报,1990(04):312-314. DOI： 10.13406/j.cnki.cyxb.1990.04.020.

Lai Songqing. CLINICAL OBSERVATION ON AHALYSANTINFARC-TASE TREATMENT FOR SCLERODERMA. [J]. Journal of Chongqing Medical University (4):312-314(1990) DOI： 10.13406/j.cnki.cyxb.1990.04.020.

摘要

蝮蛇抗栓酶治疗硬皮病还未见报道

本文治疗10例

其中系统型7例、局限型3例

具有一定疗效

Abstract

Ahalysantinfarctasum treatment for scleroderma has not been reported in the literature.This paper reports 10 cases treated with ahalysantinfarctase.7 cases were systematic scleroderma and the other 3 localized type.The result of analysis showed that this drug has certain effect for scleroderma

关键词

蝮蛇抗栓酶硬皮病

Keywords

AhalysantinfarctaseScleroderma

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰